Anthracycline-induced cardiorenal toxicity: from molecular mechanisms to clinical management - Top-Institutions - MDSpire

Anthracycline-induced cardiorenal toxicity: from molecular mechanisms to clinical management

  • By

  • Linke Jiao

  • Chao Yuan

  • Li Wang

  • Yating Zhao

  • Guoxia Zhang

  • Xinyu Yang

  • Yonghong Gao

  • Fan Yang

  • Xinye Li

  • Na An

  • Hongcai Shang

  • Yanwei Xing

  • May 12, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania, Perelman School of Medicine
    University of Pennsylvania, Perelman School of Medicine

    Philadelphia, Pennsylvania

    Key Differentiators

    • Cardiology
    • Oncology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology
    • Oncology

  • #3

    Spanish National Centre for Cardiovascular Research
    Spanish National Centre for Cardiovascular Research

    Madrid, Spain

    Key Differentiators

    • Cardiology

  • #4

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Germany

    Key Differentiators

    • Cardiology

  • #5

    City of Hope Comprehensive Cancer Center
    City of Hope Comprehensive Cancer Center

    Duarte, California

    Key Differentiators

    • Oncology
    • Cardiology

Original Source(s)

Anthracycline-induced cardiorenal toxicity: from molecular mechanisms to clinical management

  • by Linke Jiao, Chao Yuan, Li Wang, Yating Zhao, Guoxia Zhang, Xinyu Yang, Yonghong Gao, Fan Yang, Xinye Li, Na An, Hongcai Shang, Yanwei Xing

  • May 12, 2026

Related Content

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report